SUNSHINE BIOPHARMA INC's ticker is and the CUSIP is 867781403. A total of 9 filers reported holding SUNSHINE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,977 | -37.1% | 286,100 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $141,476 | -29.4% | 286,100 | 0.0% | 0.00% | -40.0% |
| Q1 2023 | $200,299 | +9.4% | 286,100 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $183,104 | -17.1% | 286,100 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $221,000 | -64.0% | 286,100 | -49.7% | 0.01% | -57.1% |
| Q2 2022 | $614,000 | – | 568,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,194,000 | $1,084,933 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,100 | $141,476 | 0.00% |
| OSAIC HOLDINGS, INC. | 11,978 | $5,916 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,179 | $9,978 | 0.00% |
| MORGAN STANLEY | 26 | $13 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 6,042 | $2,900 | 0.00% |
| New England Capital Financial Advisors LLC | 500 | $248 | 0.00% |
| UBS Group AG | 1 | $0 | 0.00% |